학술논문
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial
Document Type
Article
Author
Gershenson, David M ; Miller, Austin; Brady, William E; Paul, James; Carty, Karen; Rodgers, William; Millan, David; Coleman, Robert L; Moore, Kathleen N; Banerjee, Susana; Connolly, Kate; Secord, Angeles Alvarez; O'Malley, David M; Dorigo, Oliver; Gaillard, Stephanie; Gabra, Hani; Slomovitz, Brian; Hanjani, Parviz; Farley, John; Churchman, Michael; Ewing, Ailith; Hollis, Robert L; Herrington, C Simon; Huang, Helen Q; Wenzel, Lari; Gourley, Charlie
Source
In The Lancet 5-11 February 2022 399(10324):541-553
Subject
Language
ISSN
0140-6736